Janice Lyons, MD
-
Specialty: Radiation Oncology
View Expertise - Languages Spoken: English
Biography: Janice Lyons, MD
Expertise
Titles
- Medical Director, Radiation Oncology Regional Network, UH Cleveland Medical Center
- Director, Breast Cancer Services, Radiation Oncology, UH Cleveland Medical Center
- Professor, CWRU School of Medicine
Certifications & Memberships
- Radiation Oncology - American Board of Radiology
Education
Residency | Radiation Oncology
Radiation Oncology - Cleveland Clinic (1996 - 2000)
Internship | Rotator
Rotator - Cleveland Clinic (1995 - 1996)
Medical Education
University Of Illinois College Of Medicine At Chicago (1995)
Undergraduate
Duke University (1991)
Videos
Related Blog Articles
Less Can Be More With Hypofractionation Radiation Therapy for Breast Cancer
In recent years, cancer physicians and radiation oncologists have been whittling away at the length of time for radiation treatment. The goal: to make radiation treatment more convenient for the patient, with fewer side effects.
Seamless Care Helps Teacher Return To Classroom After Breast Cancer Treatment
Exactly one year after being diagnosed with breast cancer, teacher Alison Berger is returning to the classroom, a vivid illustration of how well a patient can recover with a strong support network at home and the hospital.
Young Mother of 3 Fights Stage IV Breast Cancer with the Help and Support of her UH Family
Alaina Koplow, had twin 3-year-olds and a 1-year-old daughter when she learned she had an advanced, rare form of breast cancer. With access to clinical trials and the newest drug therapies, she has responded well to ongoing treatment.
Breast Cancer Survivor Reflects on Life-Saving Treatment After Delivering Baby
During Sue Swiger’s second pregnancy, she was diagnosed with breast cancer. She began treatment days after delivering her daughter. She now is cancer-free, enjoying her children and good health, thanks to treatment at UH Seidman Cancer Center.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Janice Lyons did not disclose any Outside Relationships with Industry.